Evidence map›Paper›PMID 26518303›Full record

ArticleDer Urologe. Ausg. A2016

[S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].

K Höfner, T Bach, R Berges, K Dreikorn, C Gratzke, S Madersbacher, M-S Michel, R Muschter, M Oelke, O Reich and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Der Urologe. Ausg. A, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. [Fake News BPH - what is really true!]Der Urologe. Ausg. A · 2019
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

K HöfnerKlinik für Urologie, Evangelisches Krankenhaus Oberhausen, Virchowstraße 20, 46047, Oberhausen, Deutschland. klaus.hoefner@eko.de.
T BachAbteilung für Urologie, Asklepios Klinikum Harburg, Hamburg, Deutschland.
R BergesGemeinschaftspraxis Urologische und Andrologische Diagnose und Therapie, PAN-Klinik, Köln, Deutschland.
K DreikornÄrztezentrum Horn, Bremen, Deutschland.
C GratzkeUrologische Klinik und Poliklinik, Klinikum der LMU München, München, Deutschland.
S MadersbacherAbteilung für Urologie, Kaiser-Franz-Josef-Spital, Wien, Österreich.
M-S MichelKlinik für Urologie, Universitätsmedizin Mannheim, Mannheim, Deutschland.
R MuschterKlinik für Urologie und Kinderurologie, Agaplesion Diakonieklinikum Rotenburg gemeinnützige GmbH, Rotenburg (Wümme), Deutschland.
M OelkeKlinik für Urologie und Urologische Onkologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
O ReichKlinik für Urologie, Klinikum Harlaching; Städtisches Klinikum München, München, Deutschland.
C TschuschkeUrologische Gemeinschaftspraxis, Münster, Deutschland.
T BschleipferKlinik für Urologie, Andrologie und Kinderurologie, Klinikum Weiden/Kliniken Nordoberpfalz AG, Weiden, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report summarizes the relevant aspects of the S2e guideline of the German Urologists for the conservative and pharmacological treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Recommendations are given regarding watchful waiting, behavioral therapy, phytotherapy and pharmacological mono- and combination therapy. The influence of the different therapeutic options on bladder outlet obstruction (BOO) is described in detail.

Indexed as

Practice Guidelines as Topic5-alpha Reductase InhibitorsAdrenergic alpha-AntagonistsBehavior TherapyEvidence-Based MedicineGermanyHumansMalePhytotherapyProstatic HyperplasiaTreatment OutcomeUrinary Bladder Neck ObstructionUrologyWatchful Waiting5-alpha Reductase InhibitorsAdrenergic alpha-AntagonistsBehavioral therapyDrug therapy, combinationMonotherapy, drugPhytotherapyWatchful waiting

Identifiers

PMID26518303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.